Olopatadine Impurity 2 | CAS 1206456-47-4 - Request Quote
Olopatadine Impurity 2
| SZ CAT No: | SZ-O007017 |
| CAS No | 1206456-47-4 |
| Mol.F. | C18H17NO3 |
| Mol.Wt. | 295.3 |
| Inv. Status | Under QC Approval |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Olopatadine Impurity 2 is chemically N,N-Dimethyl-2-(11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetamide. Olopatadine Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Olopatadine Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Olopatadine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1206456-47-4
Purchase 1206456-47-4
Order 1206456-47-4
Enquire 1206456-47-4
price of 1206456-47-4
1206456-47-4 Supplier
1206456-47-4 Manufacturer
1206456-47-4 Exporter
buy high quality Olopatadine Impurity 2
Purchase Olopatadine Impurity 2
Olopatadine Impurity 2 suppliers
Olopatadine Impurity 2 manufacturers
Olopatadine Impurity 2 price
Order Olopatadine Impurity 2
Enquire Olopatadine Impurity 2
Olopatadine Impurity 2 cost
Olopatadine Impurity 2 Supplier
Olopatadine Impurity 2 Distributor
Olopatadine Impurity 2 for Method Validation
Olopatadine Reference Standard
Olopatadine Impurity 2 for ANDA Filing
Olopatadine Impurity 2 for Forced Degradation Studies
Olopatadine Impurity 2 Identification Standards
Olopatadine Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.